HOWARD BROOKS-KORN
Veterinary in Sharp Park, CA
License number
Michigan 6901005079
Issued Date
Jun 8, 1977
Expiration Date
Dec 31, 1996
Category
Veterinary Medicine
Type
Veterinarian
Address
Address
Sharp Park, CA 94044
Professional information
Opiopathies
US Patent:
2007023, Oct 4, 2007
Filed:
Apr 3, 2006
Appl. No.:
11/395242
Inventors:
Howard Brooks-Korn - Pacifica CA, US
International Classification:
A61K 31/485
US Classification:
514282000
Abstract:
The present invention provides novel methods for classifying, diagnosing and/or treating a group of human and veterinary ailments involving endogenous opioid concentrations. Also provided is a novel use for an existing class of compounds, the opioids, to treat opiopathic ailments, particularly paresis/paralysis, pseudo-atrophy and/or opiopathic pain, and in the manufacture of pharmaceutical and veterinary formulations therefor. The invention also relates to neuropathic, polyneuropathic, neurologic and neurogenic ailments typically characterized by paresis/paralysis. These ailments can involve an abnormal concentration of one or more endogenous opioids, or the blockade, underexpression or overexpression of one or more opioid receptors. In that regard, the invention encompasses therapeutic uses, methods and compositions employing opiates and/or their receptors. In particular, the invention relates to certain laboratory testing methods, clinical testing methods, research and development methods, business methods, methods of treatment, novel therapeutic uses, and human and veterinary pharmaceutical dosage forms, dosing regimens and formulations, especially those pertaining to opiopathy (particularly hypo-opiopathy).
Opiopathies
US Patent:
2006017, Aug 10, 2006
Filed:
Apr 3, 2006
Appl. No.:
11/395200
Inventors:
Howard Brooks-Korn - Pacifica CA, US
International Classification:
A61K 31/485, A61K 49/00
US Classification:
424010100, 514282000
Abstract:
The present invention provides novel methods for classifying, diagnosing and/or treating a group of human and veterinary ailments involving endogenous opioid concentrations. Also provided is a novel use for an existing class of compounds, the opioids, to treat opiopathic ailments, particularly paresis/paralysis, pseudo-atrophy and/or opiopathic pain, and in the manufacture of pharmaceutical and veterinary formulations therefor. The invention also relates to neuropathic, polyneuropathic, neurologic and neurogenic ailments typically characterized by paresis/paralysis. These ailments can involve an abnormal concentration of one or more endogenous opioids, or the blockade, underexpression or overexpression of one or more opioid receptors. In that regard, the invention encompasses therapeutic uses, methods and compositions employing opiates and/or their receptors. In particular, the invention relates to certain laboratory testing methods, clinical testing methods, research and development methods, business methods, methods of treatment, novel therapeutic uses, and human and veterinary pharmaceutical dosage forms, dosing regimens and formulations, especially those pertaining to opiopathy (particularly hypo-opiopathy).